AzTrials
AzTrials

Cardiovascular FitnessNCT06912932

Physiological and Perceptual Responses During 4-Second Exercise

A study testing Preventive in people with Cardiovascular Fitness, run by University of Texas at Austin at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the acute effects of different intensities (i.e., 50, 75, and 100% of maximal anaerobic power) of 4-s sprint interval exercise on physiological responses. Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Cardiovascular Fitness
What is being tested?
Preventive
Could I receive a placebo?
No, everyone receives an active treatment
How many people
11 participants
Where
1 siteUnited States
Study dates
4 Apr 2023to 2 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Young (18-30),
  • Healthy,
  • Recreationally active, but untrained (not meeting ACSM's recommendations of 150 min/week of moderate-vigorous aerobic exercise)

Who cannot join

  • Cardiovascular disease
  • Smoking
  • Subjects who were exercising regularly (>75 min/week) were excluded.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Human Performance Laboratory, Department of Kinesiology and Health Education, the University of Texas at Austin

    Austin, Texas, 78712

Other trials in United States

About this study

Official title: The Effects of The Exercise Intensity and Rest Duration on Physiological and Perceptual Responses During 4-Second Sprint Interval Exercise

The purpose of this study is to investigate the acute effects of different intensities (i.e., 50, 75, and 100% of maximal anaerobic power) of 4-s sprint interval exercise on physiological responses. Secondly, it will determine the relationship between intensity and recovery duration (i.e., 15, 30, or 45-s) that will stimulate the cardiovascular and metabolic systems.

Read the detailed description

Background Short sprint interval training (sSIT) is typically performed at maximal intensity, generating power far above what is needed to reach peak oxygen consumption (VO₂peak). However, the physiological effects of submaximal sprint intensities and different recovery periods are not well understood.

Study Aim This study examined how power output and oxygen consumption (VO₂) respond to repeated 4-second sprints at 50%, 75%, and 100% of maximal power (Pmax) with rest periods of 15, 30, or 45 seconds.

Methods Eleven recreationally active participants completed nine trials, each consisting of thirty 4-second cycling sprints under different intensity and recovery conditions.

Being tested
Preventive
Keywords
exercise, cardiovascular fitness, sprint, vo2max, interval training
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PreventiveBehavioural

    systematically investigate the acute physiological responses induced by three levels of %Pmax intensities (50% and 75% of Pmax and all-out efforts) with three varying rest periods (15, 30, and 45-s) between thirty 4-s sprints.

Study groups in NCT06912932
Study groupRoleWhat they receive
50% Pmax and 15-s rest durationActive comparatorParticipants used 50% Pmax and 15-s rest duration during 30 bouts of 4-s sprint interval training.
Receives: Behavioral: Preventive
50% Pmax and 30-s rest durationActive comparatorParticipants used 50% Pmax and 30-s rest duration during 30 bouts of 4-s sprint interval training.
Receives: Behavioral: Preventive
50% Pmax and 45-s rest duration4Active comparatorParticipants used 50% Pmax and 45-s rest duration during 30 bouts of 4-s sprint interval training.
Receives: Behavioral: Preventive
75% Pmax and 15-s rest durationActive comparatorParticipants used 75% Pmax and 15-s rest duration during 30 bouts of 4-s sprint interval training.
Receives: Behavioral: Preventive
75% Pmax and 30-s rest durationActive comparatorParticipants used 75% Pmax and 30-s rest duration during 30 bouts of 4-s sprint interval training.
Receives: Behavioral: Preventive
75% Pmax and 45-s rest durationActive comparatorParticipants used 75% Pmax and 45-s rest duration during 30 bouts of 4-s sprint interval training.
Receives: Behavioral: Preventive
All-out Pmax and 15-s rest durationExperimentalParticipants used all-out Pmax and 15-s rest duration during 30 bouts of 4-s sprint interval training.
Receives: Behavioral: Preventive
all-out Pmax and 30-s rest durationExperimentalParticipants used all-out Pmax and 30-s rest duration during 30 bouts of 4-s sprint interval training.
Receives: Behavioral: Preventive
all-out Pmax and 45-s rest durationExperimentalParticipants used all-out Pmax and 45-s rest duration during 30 bouts of 4-s sprint interval training.
Receives: Behavioral: Preventive

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cardiovascular changes

    The %VO2peak associated with repeated submaximal power sprints (%Pmax), particularly when paired with varying rest periods, remains unknown. The aim of this study was to systematically investigate the cardiovascular changes for better exercise programming, measured in mL/min/kg.

    Measured: From enrollment (Day 1) to the end of treatment (9 trials) (Day 11), through study completion, an average of 5 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Apr 2025
  2. Study start4 Apr 2023
  3. Primary completion2 Oct 2024
  4. Study completion2 Oct 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
11 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06912932
Sponsor's protocol ID
STUDY00004240-CR01
Status last verified
Mar 2025
First submitted
24 Mar 2025
Last updated
6 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Preventive in people with Cardiovascular Fitness, run by University of Texas at Austin at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cardiovascular changes (time frame: From enrollment (Day 1) to the end of treatment (9 trials) (Day 11), through study completion, an average of 5 weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in